1. Introduction {#sec1}
===============

The Flaviviridae family,*Flavivirus* genus, consists of a variety of viruses transmitted by blood-feeding arthropod species, several of which represent emergent or reemergent pathogens including*Zika* (ZIKV),*Dengue* (DENV),*Yellow Fever* (YFV),*Japanese Encephalitis* (JEV), and*West Nile* (WNV) viruses. ZIKV, a previously neglected member of the genus, has recently been the subject of concern and research since it has been linked to congenital developmental deficits and neurological syndromes \[[@B1]--[@B8]\].

*Flavivirus* virions are composed of a single positive-strand RNA genome, packaged by the viral capsid protein (C) in a host-derived lipid bilayer and surrounded by 180 copies of two structural proteins, envelope (E) and membrane (M) \[[@B9], [@B10]\]. The genome is translated into a single polyprotein and subsequently cleaved by viral and host proteases into three structural proteins (C, prM/M, and E) and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) \[[@B9], [@B11]\].

A successful innate immune response by the host depends on the efficient detection of the invading pathogen.*Flavivirus* use their structural glycoproteins to attach to the host cell, interacting with several receptors, which trigger endocytosis pathways. One of the proteins important in this process is structural E protein with plays a role in receptor binding, viral entry, and membrane fusion, whereas prM assists in folding, assembly, and function of the E protein \[[@B9], [@B11]\]. The ZIKV uses the envelope (E) glycoprotein for entry into specific cell types such as epidermal keratinocytes, fibroblasts, immature dendritic cells, and stem-cell-derived human neural progenitors \[[@B12]\]. Sequence comparisons of the E glycoprotein of ZIKV with the other members of the Flaviviridae family indicate an unusual degree of variability including glycosylation within the ZIKV strains \[[@B12]\]. These differences in glycosylation may determine a characteristic affinity for human target proteins.

Three major attachment factors for*Flavivirus* are heparin sulfates, dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN, CD209 antigen), and DC-SIGNR (CLEC4M), which interact with N-linked glycans of the viral E glycoprotein. DC-SIGN itself does not provide an essential internalization signal during DENV entry, suggesting that additional entry factors exist. It seems that ZIKV may also use GAGs (glycosaminoglycans) as attachment factors to enter the host cell \[[@B13]\].

Another molecule identified as an entry factor for DENV is AXL \[[@B14]\] which belongs to the TYRO3 AXL MER (TAM) family, a group of tyrosine kinase receptors involved in the clearance of apoptotic cells and regulation of innate immunity \[[@B15], [@B16]\]. However, for ZIKV, some studies confirm that AXL is not the key receptor for the viral infection of human neural progenitor cells \[[@B12], [@B17]--[@B20]\].

Receptor-mediated endocytosis is a prerequisite for fusion and uncoating of all known Flaviviridae family members. Clathrin-dependent uptake has been described as the major endocytosis mechanism, but alternative entry routes exist and may be used in a strain-specific manner \[[@B21]\].

After endocytic uptake and acidification of the endosomal lumen, the viral surface glycoproteins undergo a conformational change and induce fusion of the limiting endosomal membrane and the viral envelope. Disassembly of the viral capsid ("uncoating") delivers the RNA genome to the cytoplasm, which completes the entry process \[[@B21]\].

After release of the genome into the cytoplasm, ZIKV replicates through a negative strand intermediate \[[@B9], [@B12]\]. For the nonstructural proteins synthesis and posttranslational modifications*Flavivirus* use the virus-induced membranous vesicles derived from the endoplasmic reticulum and Golgi complex by exploiting membrane trafficking \[[@B22]\].

Below we describe the current evidence of the "hijacking" of each of the nonstructural proteins with the host cell. Upon synthesis, the*Flavivirus* nonstructural proteins may play different functions within human host cells or may follow host exocytosis pathways and act outside the host cell. That is the case of the nonstructural protein NS1, a 46--55 KDa glycoprotein containing 2-3 glycosylation sites \[[@B23], [@B24]\]. After polyprotein processing, NS1 is translocated into the lumen of the ER and released from E protein by ER resident signal peptidase \[[@B23], [@B25]\]. The C-terminus is cleaved by an unidentified ER host protease \[[@B26]\] and glycosylated by the addition of high-mannose carbohydrates \[[@B27]\]. After a rapid dimerization, NS1 acquires a partially hydrophobic behaviour and can associate with cell membranes \[[@B11], [@B12], [@B28], [@B29]\]. NS1 protein can associate with the membrane through a glycosylphosphatidylinositol (GPI) anchor \[[@B30]\]. NS1 has also been described as being secreted to the extracellular environment \[[@B11], [@B28], [@B29]\]. The secreted form of NS1 traffics through the Golgi secretory pathway in mammalian cells, and the carbohydrate moieties are processed to more complex sugars that are then secreted as a soluble hexamer of \~300 kDa associated with lipids \[[@B11], [@B31]--[@B33]\].

NS2A is a multifunctional protein with roles in virion assembly \[[@B34], [@B35]\], RNA replication \[[@B36], [@B37]\], membrane permeation \[[@B38]\], and dissemination from infected mosquito midguts \[[@B8], [@B39], [@B40]\]. NS2A has also been shown to act as an interferon antagonist in different*Flavivirus* \[[@B8], [@B41], [@B42]\]. The NS2B protein interacts with NS3 to form a stable complex which functions as a serine protease \[[@B43]\] which has been shown to interfere with IFN-I induction \[[@B44]\]. ZIKV\'s NS3 protein contains a protease and a helicase domain that in several*Flavivirus* act independently of each other \[[@B45]\].

NS4B is an important IFN-I signaling antagonist during DENV2 infections by inhibiting the JAK/STAT pathway and antagonising STAT1 phosphorylation \[[@B46]\]. Unlike DENV, YFV NS4B blocks RIG-I through an interaction with STING. This highlights strain-specific variations used for IFN suppression between different*Flavivirus* \[[@B8]\].

NS5 offers some protection for the virus by producing capped viral RNA, enabling host RNA mimicry through its methyltransferase activity \[[@B47]--[@B50]\]. NS5 displays two enzymatic activities via the N-terminal methyltransferase domain and the C-terminal RNA dependent RNA polymerase (RdRp), which replicates viral RNA \[[@B51], [@B52]\].

Despite the description of receptors, entry factors or pathways for*Flavivirus* action, based on several experimental approaches, the specific cell surface receptor and endocytosis complexes, fusion mechanisms, and entry pathways for ZIKV, are not yet clear.

Although there is a similar genomic organization between ZIKV and DENV, nonstructural proteins exhibit low homology \[[@B53]\]. The recent publication of the spatial organization of the ZIKV proteins during the intracellular passage of the virus \[[@B54]\] and the high recombination frequencies seen in it suggest that ZIKV has potentially evolved faster and attained the ability to exploit multiple cell surface receptors and cellular factors to facilitate infection in a variety of cells types, differing from other*Flavivirus*. These evidences prompted an investigation of new ZIKV targets as a result of ZIKV specific PPIs established with the human host cell. Our approach was to use a computational-based analysis which is faster and more cost-effective than experimental methods and may be valuable for generating preliminary models.

This article presents information on potential Protein-Protein Interactions (PPIs) established between ZIKV structural and nonstructural proteins and human host proteins predicted by the OralInt algorithm \[[@B55]\]. The predicted PPIs are discussed considering the different mechanisms that have been proposed for*Flavivirus* and the intracellular localization of the viral proteins during the infection cycle.

2. Materials and Methods {#sec2}
========================

This article aims at the clarification of the molecular entry and dissemination mechanisms of*Zika* virus by using a machine learning model for predicting the interactions established between the virus and the host proteins (PPI). These predictions are subsequently explored by a functional analysis based on the collection, organization, and interpretation of published information.

2.1. Human-*Zika* Virus Interactome Prediction {#sec2.1}
----------------------------------------------

The prediction of the PPIs established between*Zika* virus and human proteins was performed using the OralInt tool developed by our group \[[@B55]\] which allows the prediction of interspecies PPIs. The input data were the human reviewed proteome (Proteome ID: UP000005640) (20199 proteins) and the ZIKV polyprotein sequence (Uniprot: Q32ZE1) using each of the processed proteins, both deposited in UniProt \[[@B56]\] as of January 2017. Of the 14 ZIKV proteins listed in UniProt, only the 10, which are currently considered functionally important, were used. Throughout this document, the proteins are identified by either their UniprotKB AC, gene, or protein name depending on the analysis performed.

The predicted interactions were stratified and analyzed according to the prediction score (0.9--1.0: very high confidence; 0.7--0.9: high confidence; 0.4--0.7: medium confidence; 0.1--0.4: low confidence). Interactions with scores lower than 0.1 were discarded. An Excel file with predicted PPIs used in this article is provided as supplementary material.

2.2. Visualization of PPI Network between Human and*Zika* Virus {#sec2.2}
---------------------------------------------------------------

A network of the predicted very high confidence PPIs (score ≥ 0.9) was generated using Cytoscape 3.5.0 \[[@B57]\]. To facilitate data interpretation, a network analysis was performed using the Network Analyzer Tool from Cytoscape, and visualization was obtained by mapping the node size onto degree (number of PPIs for each node) and the edge size onto score. An interactive network diagram created with the latest version of Cytoscape is included in the supplementary material.

2.3. Data of Protein Expression after*Zika* Virus Infection {#sec2.3}
-----------------------------------------------------------

To complement the functional analysis of the proteins involved in viral entry and virulence, data on the quantification of different proteins upon viral infection were used. As of March 2017, there were 2 studies with a large scale protein quantification in 2 different types of cell: (1) infected primary human fibroblasts \[[@B17]\] and (2) human cortical neural progenitors cells (hNPCs) \[[@B58]\]. In Hamel et al. 2015, the values represent fold inductions of mRNA copy numbers in infected cells relative to mock-infected cells and fold change values after 6 and 24 h are presented \[[@B17]\]. For hNPCs, fold change values were calculated from the log 2 values presented in the article using the inverse function *y* = 2^∧^*x* to ensure data standardization; this enables the comparison of the values obtained in the two studies. To facilitate interpretation, fold changes intervals were normalized by recalculating values between 0 and 1 as -(1/fold change). Protein quantification data used for discussion of results is available as an Excel file in the supplementary material.

2.4. Analysis of PPIs by Functional Role in*Zika* Virus Infection {#sec2.4}
-----------------------------------------------------------------

For the study of the molecular mechanisms potentially involved in viral entry into the host, and subsequently intracellular affected mechanisms, an analysis of the predicted PPIs between the viral proteins and the host endocytosis receptors, immune response, and cytosolic host response proteins was performed. For this analysis, only the interactions with a score ≥ 0.2 were considered.

To verify which human proteins identified as having the potential to interact with the viral envelope and membrane proteins (score ≥ 0.2) have been described as membrane receptors involved in viral entry into the host cell, two approaches were followed:

\(1\) KEGG\'s \[[@B59], [@B60]\] mapping tool was used to identify proteins related to endocytosis.

\(2\) A review of the receptors involved in macropinocytosis of Flaviviridae \[[@B61]\] was used.

To evaluate how ZIKV modulates the host immune response, the PPIs established between the different ZIKV proteins and the host receptors and other proteins that have an effector or a signaling role in the immune response were analyzed. These data were integrated with data from expression fold change available for skin and hNPCs obtained as explained in [Section 2.3](#sec2.3){ref-type="sec"} of the Material and Methods.

The initial sensing of infection is mediated by innate pattern recognition receptors (PRRs), which include Toll-like, RIG-I-like, NOD-like, and C-type lectin receptors. The intracellular signaling cascades triggered by these PRRs lead to transcriptional expression of inflammatory mediators that coordinate the elimination of pathogens and infected cells. To identify the molecular mechanisms used by ZIKV to bypass this defense system, PPIs predicted by OralInt between human and viral nonstructural proteins were considered.

VirHostNet 2.0 \[[@B62]\] complemented with the information present in ViralZone \[[@B63]\] were used to identify PRRs already described as being involved in ssRNA viruses recognition.

2.5. *Zika* and Dengue Virus Protein Homology Determination {#sec2.5}
-----------------------------------------------------------

The homology between the nonstructural ZIKV (strain Mr 766) and DENV (*Dengue* virus type 1 (strain Nauru/West Pac/1974) (DENV-1)) proteins was determined by using the Clustal Omega \[[@B64]\] algorithm provided as an Alignment Tool in UniProt \[[@B56]\].

3. Results and Discussion {#sec3}
=========================

3.1. Human-*Zika* Virus Predicted Interactome {#sec3.1}
---------------------------------------------

Using OralInt \[[@B55]\], human-ZIKV interactome was determined and a summary of the results is presented in [Table 1](#tab1){ref-type="table"}. The predicted PPIs are complemented with the annotation of the proteins which have been quantified in different human cells upon ZIKV infection. The quantification data pertain to transcriptomics data on the human proteins expressed by skin \[[@B17]\] and hNPCs cells \[[@B58]\] upon ZIKV infection. From a total of 1898 high to medium score (0.7--1) predicted PPIs, there are transcriptomics data on 726 of the human proteins involved. From these, the PPIs established between human and E and M ZIKV structural proteins are especially relevant for the identification of human target receptors.

Up to now, there is only one study that experimentally validates PPIs related to ZIKV infection \[[@B65]\]. OralInt predicts all of the 143 experimentally described interactions between NS2A and the human proteins and 33 of those are predicted with high or medium confidence.

[Table 2](#tab2){ref-type="table"} presents the number of human proteins interacting with a specific ZIKV protein, for which the PPIs have a score ≥0.4 and the annotation of the up- or downregulation of the human protein according to the values obtained in previous experiments reported in the literature \[[@B17], [@B58]\]. Since there has been interest in the identification and quantification of salivary biomarkers for this infection, proteins previously identified in saliva are also annotated \[[@B66], [@B67]\].

The network of PPIs with a very high confidence score (≥0.9) is presented in [Figure 1](#fig1){ref-type="fig"}. No PPIs with the highest score were identified for the C and NS4A proteins. The viral proteins establishing the largest number of interactions are NS2B (protein which forms a complex with NS3 showing serine protease activity), NS4B, and E (the main protein binding to membrane receptors). Proteins with available quantification are also identified.

From the proteins interacting with the multifunctional ZIKV NS2B protein ([Figure 1](#fig1){ref-type="fig"}), the Rho-related BTB domain containing 3 (RHOBTB3) is of special note, since it is a Rab9-regulated ATPase required for vesicle transport and docking at the Golgi complex \[[@B68]\]. The prediction of this PPI with a high score is evidence that ZIKV interferes with vesicular organization and host docking mechanisms. Another protein establishing high score PPIs and involved in vesicular traffic is BICD1 (bicaudal D homolog 1 (Drosophila)) which regulates coat complex coatomer protein I- (COPI-) independent Golgi-endoplasmic reticulum transport by recruiting the dynein-dynactin motor complex \[[@B68]\]. Similarly, silencing and CRISPR/Cas9 knockout screens have previously identified another GTase Rab (RAB5C) and Rab-activating guanosine diphosphate/guanosine triphosphate exchange factors, GEFs (RABGEF), as vesicular transport factors contributing to*Flavivirus* effective invasion of the host cell \[[@B21]\].

3.2. New Endocytosis Pathway Targets Used by*Zika* Virus {#sec3.2}
--------------------------------------------------------

Considering PPIs with a score ≥ 0.2 established between E and M ZIKV proteins and human membrane receptors, it is possible to identify potential entry mechanisms used by ZIKV.

[Table 3](#tab3){ref-type="table"} presents the receptors that ZIKV may use in both clathrin-dependent and independent pathways of endocytosis for infecting human cells. For each human to ZIKV E and M protein PPI, the respective score is presented. This information is completed with data from the quantification available in the literature \[[@B17], [@B58]\].

Regarding the use of receptors involved in clathrin-dependent endocytosis by ZIKV, the greater scores are for PPIs established with the GRPCR and RTK type receptors. The interaction of ZIKV E protein with the beta-2 adrenergic receptor (ADRB2) of the GRPCR family, which mediates the catecholamine-induced activation of adenylate cyclase through the action of G proteins, is predicted with a score of 0.4. The PPI established between the ZIKV M protein and the ADRB3, a beta-3 adrenergic receptor, also has a 0.4 score. The RTK receptor type, namely, hepatocyte growth factor receptor (MET), which during embryonic development has a role in gastrulation, development, and migration of muscles and neuronal precursors, angiogenesis, and kidney formation, establishes with ZIKV E protein a PPI with 0.4 score.

Belonging to the GRPCR type receptors, the CCR5 (chemokine C-C motif receptor 5) and CXCR4 (chemokine C-X-C motif receptor 4) both establish interactions with ZIKV E protein having a score of 0.2.

From the RTK type receptors, ERBB4, a tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins, together with the EGF family members, regulates development including the central nervous system. Therefore, they are worthy of special note due to their potential impact in central nervous system development.

[Table 3](#tab3){ref-type="table"} identifies 10 receptors for clathrin-independent endocytosis. AXL receptor which belongs to the TYRO3 AXL MER (TAM) family, a group of tyrosine kinase receptors involved in the clearance of apoptotic cells and regulation of innate immunity \[[@B15], [@B16]\], is the best described target of*Flavivirus*. It has been shown that AXL is also the primary ZIKV entry cofactor on human umbilical vein endothelial cells (HUVECs) and that ZIKV uses AXL with much greater efficiency than DENV or WNV, by binding the AXL ligand GAS6 which recognizes phosphatidylserine (PS) exposed at the surface of the viral envelope and bridges the viral particle binding to the AXL receptor. This mechanism of viral entry, based on PS exposure, has been termed viral apoptotic mimicry \[[@B61]\]. From OralInt\'s results we can conclude that E ZIKV protein establishes a PPI with AXL with a 0.2 score, having the potential of interacting also with GAS6 with a score of 0.1. With M ZIKV protein, GAS6 establishes a PPI with a score of 0.2.

Once AXL is activated, it mediates signaling through its tyrosine kinase domain to dampen type I interferon (IFN1) signaling and facilitate infection \[[@B14], [@B69], [@B70]\]. Since AXL is expressed on primary human placental cells, endothelial cells, fibroblast cells, amniotic epithelial cells, trophoblast progenitors, and macrophages (Hofbauer cells) the maternal-fetal transmission of ZIKV is facilitated \[[@B12], [@B71]--[@B73]\]. AXL was recently shown to support ZIKV infection of human foreskin fibroblasts \[[@B17]\] and its expression was noted in the brain and neural progenitor cells \[[@B74]--[@B76]\].

According to our PPI scores, the TIM type receptor was the highest for the ZIKV clathrin-independent endocytosis mechanisms. Within that group of receptors, the hepatitis A virus cellular receptor 2 (HAVCR2) establishes a PPI with a 0.4 score with ZIKV protein E. However, other receptors also seem to interact with ZIKV proteins, namely, the caveolin-3 (CAV3) which establishes a PPI with M protein having a score of 0.6. Caveolins like CAV2 and CAV3 act as scaffolding proteins within caveolar membranes that interact directly with G-protein alpha subunits and can functionally regulate their activity. Internalization via caveolae is not a constitutive process but only occurs upon cell stimulation. It has been described that caveosomes participate in the transport of the simian virus 40 and other pathogens from the cell surface to the endoplasmic reticulum \[[@B77]\]. Caveolin-2 is most prominently expressed in fibrous and adipose tissue and caveolin-3 is restricted to striated and smooth muscle. We hypothesize that this may be another pathway through which maternal-fetal transmission occurs.

The M protein of ZIKV also establishes a PPI with CD81 with a 0.4 score. Both E and M proteins establish PPIs with claudin-1 (CLDN1) with a score of 0.3 and it has been shown that the expression of this protein had a 2.5-fold increase upon ZIKV infection. CLDN1 plays a major role in tight junction-specific obliteration of the intercellular space through calcium-independent cell-adhesion activity that regulates the permeability of epithelia. Claudin-1 and CD81 have also been related to the HCV entry into host cell \[[@B59], [@B60]\].

It is known that membrane proteins when interacting with other proteins (cognate ligands) are subject to conformational changes. We think that the same happens when the E ZIKV structural protein binds to the host membrane receptors and causes the exposure of M protein interaction domains. It has been described that*Flavivirus* structural proteins assume many asymmetric states \[[@B78]\] and are in continuous dynamic motion \[[@B79]\], which likely exposes patches of the virion membrane \[[@B80]\]. Both facts would explain why ZIKV M protein might interact with the host cell receptors showing a high score, as what happens in the PPIs established with CAV3 and CD81.

Additionally, [Table 3](#tab3){ref-type="table"} shows the scores of PPIs established between ZIKV and C-type lectins dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), a pathogen-recognition receptor expressed on the surface of immature dendritic cells involved in initiation of primary immune response that mediates the endocytosis of pathogens \[[@B17]\], and DC-SIGN-related protein (L-SIGN). Both E and M ZIKV proteins establish PPIs with a score 0.2 with DC-SIGN and with the C-type lectin domain family 4 member M (CLEC4M), a L-SIGN type receptor for mannose-like carbohydrates \[[@B81]\].

3.3. New Immune Targets Used by*Zika* Virus {#sec3.3}
-------------------------------------------

ZIKV modulation of the immune response mechanisms may be seen as an action controlled by the viral E and M structural proteins which bind and activate human receptors or interact with other membrane proteins or even bind extracellular proteins impairing their action. Once the nonstructural proteins are produced they may exert their function by binding and/or modifying the host proteins available. Protein synthesis of ZIKV proteins follows the endomembrane trafficking system in a similar fashion as to what happens with the host proteins up to the Golgi complex where glycosylation ends. This whole pathway has been demonstrated for NS1 and this nonstructural protein may also be secreted just as the host proteins and exert its actions in extracellular compartments.

In [Table 4](#tab4){ref-type="table"}, PPIs established between different ZIKV proteins and host receptors and other proteins with an effector or a signaling role in the immune response are presented. Additionally, information relative to the fold change is annotated for skin and hNPCs when available \[[@B17], [@B58]\].

IFN and TLRs receptors are important to convey signals to the cell and initiate antiviral defense mechanisms. Whether ZIKV is able to bind IFN receptors is still not clear. OralInt predicts PPIs between ZIKV E protein and IFNAR1/IFNAR2 receptor subunits, with scores 0.3 and 0.2, respectively ([Table 4](#tab4){ref-type="table"}). After type I IFN binding to IFN receptor, the signal pathway leads to the induction of an antiviral state \[[@B13], [@B82]\].

The PPI scores with ZIKV E protein and TLR2 or TLR4 are 0.3. ZIKV E and M proteins can both interact with TLR6 (0.2 score).

It has been demonstrated that nonstructural proteins of*Flavivirus* may interact with TLR receptors. In the case of DENV, it was shown that NS1 (probably the soluble hexamer) binds TLR4 on the surface of CD14+ monocytes and induces cellular activation, cytokine production, and vascular permeability, a similar response triggered by the bacterial LPS \[[@B11]\]. The results presented in [Table 4](#tab4){ref-type="table"} show that all ZIKV proteins, except NS3, establish PPIs with TLRs with scores ranging from 0.2 to 0.5.

Complement proteins are an important part of the innate immune response and as signaling molecules for different types of immune cells.

DENV NS1 can attenuate activation of the classical, lectin, and alternative pathways by interacting with complement proteins and their regulators \[[@B83]\].

C8B, a constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells, is the protein that establishes PPIs with the highest scores with ZIKV proteins. M ZIKV protein interacts with C6 and C8B with scores of 0.7 and 0.6, respectively.

Cytokines and chemokines may interact with structural and nonstructural ZIKV proteins ([Table 4](#tab4){ref-type="table"}) with scores of 0.2--0.7 for both.

3.4. New Immune Modulation Pathway Targets Used by*Zika* {#sec3.4}
--------------------------------------------------------

The coevolution between*Flavivirus* and their hosts has taken place over a long period. Host cells have developed multiple branches of innate immune system to keep the virus invasion and replication under control \[[@B84]\]. Conversely the viruses have developed different mechanisms to evade the induction of an antiviral state by the host cell and in some cases the prevention of the triggering of the apoptotic state of the host cell. A synergistic effect of nonstructural proteins to restrict cellular antiviral responses at multiple levels has been demonstrated \[[@B13]\].

[Table 5](#tab5){ref-type="table"} presents the predicted PPIs established between the nonstructural proteins of ZIKV and proteins of the host pathways leading to an antiviral state (IFNs) and proinflammatory cytokine (TNF*α*) synthesis which are depicted in [Figure 2](#fig2){ref-type="fig"}. The integration of fold change data in skin and hNPCs in [Figure 2](#fig2){ref-type="fig"} allows the evaluation of the pathways which may occur in these two cell types during ZIKV infection.

Several PRRs have been demonstrated as being activated for different*Flavivirus*. These include Toll-like receptors (TLR) mediated responses, specific nucleic acid receptor activation such as RIG-I and PKR, and the mitochondrial antiviral immunity (MAV) and IFN receptors dependent pathways. [Figure 2](#fig2){ref-type="fig"} also integrates the signaling pathways dependent on endocytosis receptors which were previously discussed ([Table 3](#tab3){ref-type="table"}).

The detection of cytoplasmic viral RNA \[[@B85]\] is accomplished by RLRs as DDX58 (the retinoic acid inducible gene-1) (RIG-I), a RNA helicase that recognizes viral RNA present within the cytoplasm and melanoma differentiation-associated protein 5 (MDA5) \[[@B86]\].

RIG-I recognizes short RNA ligands with 5′-triphosphate caps. MDA5 recognizes long kilobase-scale genomic RNA and replication intermediates. Ligand binding induces conformational changes and oligomerization of RLRs that activate the signaling partner MAVS on the mitochondrial and peroxisomal membranes. This signaling process is under tight regulation, dependent on posttranslational modifications of RIG-I and MDA5. Both contain a helicase domain and a C-terminal domain, which are involved in the binding of viral RNA. This then signals through IRF3/7 activating the transcription of IFNs \[[@B87]\].

The RIG-I molecule is upregulated with a fold change of 4.9 after 24 hours of infection of fibroblasts and of the TRIM25 an E3 ubiquitin ligase, which further activates RIG-I ([Table 5](#tab5){ref-type="table"}). TRIM25 functions as an E3 ligase, which adds poly-ubiquitin chains to the amino-terminal of RIG-I \[[@B87]\]. This is thought to facilitate the interaction of RIG-I with MAVS, thus modulating downstream signaling of the IFN-I response.

RIG-I has been demonstrated as modulating DENV antiviral response \[[@B88]\]. Through the direct interaction and modulation of I*κ*B kinase *ε*, an important kinase involved in IFN-I induction, DENV NS2B/NS3 disrupts RIG-I, the signaling pathway.

ZIKV nonstructural proteins establish PPIs with scores of 0.2 with RIG-I, whereas PPIs established with TRIM25 and MDA5 have scores between 0.3 and 0.6. The RNA sensing mechanism MDA5, also known as interferon induced with helicase C domain 1 \[[@B88]\] upon ZIKV infection of fibroblasts, has a similar variation to RIG-I, decreasing initially and being upregulated with a fold change of 7.3 after 24 hours ([Table 5](#tab5){ref-type="table"}). This evidence points to a delayed cell response, which seems to be dependent on the presence of several ssRNA molecules which only happens after the virus initiated replication within the host cell.

Recently, it has been shown that when ZIKV infects the primary human placental macrophages and placental cytotrophoblasts, it induces the production of IFN-*α*, proinflammatory cytokines, and antiviral genes such as RIG-I and MDA5 \[[@B89]\]. Also during infection, ZIKV stimulates cell death and induces type I interferon (IFN) response and proinflammatory cytokines that disrupt the placental barrier leading to neurological disorders such as microcephaly \[[@B74]\].

The IFNs bind to a heterodimeric transmembrane receptor which results in the recruitment and activation of tyrosine kinases, JAK1 and TYK2, through auto- and transphosphorylation. This process drives the recruitment and subsequent phosphorylation of the cytoplasmic transcription factors, STAT1 and STAT2, which translocate to the nucleus and associate with IRF9 to activate IFN genes.

NS5 has been described as a potent*Flavivirus* IFN-I antagonist \[[@B90]\] by STAT1/2 activation or translocation. DENV NS5 binds and degrades STAT2 by targeting it for ubiquitin-mediated proteasomal degradation \[[@B91]\].

NS2B and NS4B from ZIKV establish PPIs with a 0.4 score with JAK1 and a score of 0.3 with TYK2. Both tyrosine kinases, JAK1 and TYK2, are upregulated in hNPCs under ZIKV infection ([Table 5](#tab5){ref-type="table"}). All the nonstructural ZIKV proteins establish PPIs with STAT1 (scores 0.5--0.8). Similarly, experimental studies have confirmed that ZIKV NS5 is required for the proteasomal degradation of the STAT2 in humans \[[@B92], [@B93]\]. However, OralInt\'s score for STAT2 PPIs established with viral proteins is only 0.3. We propose that STAT1 may be a potential ZIKV target.

During*Flavivirus* infections TLR7, TLR8, TLR9, and the dimerization complex TLR7 with TLR9, which identify RNA, are important factors for virus detection. All TLRs mentioned signal through an intermediate protein, MYD88, which eventually leads to activation of the nuclear factor kappa-B (NFKB), a pleiotropic transcription factor present in almost all cell types. One of the cytokines which results from the activation of this pathway, TNF-alpha, is downregulated ([Table 5](#tab5){ref-type="table"}) which indicates that, despite being noticed by the cell, the virus somehow inhibits, at least temporarily, a systemic inflammatory response by avoiding the release of proinflammatory cytokines.

NS1 and NS2A ZIKV proteins can interact with MYD88 (0.4 score). NS4B establishes a PPI with a score of 0.3 with MYD88. Both NS2B and NS5 interact with MYD88 with a score of 0.4. Curiously, NS2B, the serine protease of ZIKV, can interact with NFKB with a score of 0.4 and may result in the degradation of the transcription factor by the activity of the viral protease.

It was recently demonstrated that IFN*β* restricts replication of ZIKV and promotes autophagic degradation of NS2B/NS3 complex, which explains the host innate immune protective defense against ZIKV. As the ubiquitination of NS2B/NS3 is enhanced by IFN*β* treatment and STAT1 is required for the degradation of NS2/NS3, the potential IFN-inducible E3 ligases might be involved in this process. Many E3 ligases such as tripartite motif (TRIM) proteins family members, including TRIM25, can be upregulated by IFN through STAT1 \[[@B94]\].

The PPIs predicted by OralInt show high scores for interaction of TRIM25 (NS2B---0.4). The PPI score between IFN*β* and NS2B is 0.2 and with NS3 is 0.3.

The fact that there is a low homology between the nonstructural DENV and ZIKV proteins, as determined by the UniProt Alignment Tool \[[@B56]\], especially for NS1 (54%), NS2A (24%), NS2B (37%), NS3 (65%), and NS5 (65%), further supports the search for different targets and the establishment of different PPIs than those described for DENV.

Although ZIKV uses many of the main pathways exploited by other*Flavivirus* to infect human cells, which is represented in the PPIs predicted by OralInt, new ZIKV targets are possible within the same general pathways based on higher score of the PPIs obtained.

4. Conclusion {#sec4}
=============

The analysis of the ZIKV-human interactome reveals that this virus shares some of the targets and strategies with other*Flavivirus* to infect human host cells. However, we found new interactions that support the existence of different human protein targets which may be used specifically by ZIKV to invade and disrupt the host cell homeostasis ([Figure 3](#fig3){ref-type="fig"}). Despite having a similar genome organization as other*Flavivirus,* the low homology between ZIKV and DENV nonstructural proteins justifies the analysis and in silico search for new targets and we believe that these are worthy of further attention. The computational approach for the discovery of new targets and mechanisms of ZIKV-human infection is an expedite and efficient way of making new proposals which should be experimentally confirmed by quantitative proteomics analysis enabling the development of innovative preventive (vaccines) or therapeutic approaches.
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###### 

Excel file with Protein-Protein Interactions (PPIs) between human and ZIKV, predicted in this work and respective scores. Excel file with the protein quantification data, obtained from the literature, used in the discussion of the results. Interactive network diagram created with Cytoscape (.CYS) freeware software downloadable at cytoscape.org \[<http://cytoscape.org>\].

###### 

Click here for additional data file.

![Network of OralInt predicted PPIs (score ≥ 0.9) established between ZIKV proteins (blue) and human proteins (orange). The size of the node denotes the degree (number of interactions established). Red denotes underexpressed and green overexpressed proteins. Expression data from Tang et al. 2016 \[[@B58]\]. Diagram generated with Cytoscape V3.5.0 \[[@B57]\].](BMRI2017-1734151.001){#fig1}

![Diagram representing membrane and cytosolic targets of ZIKV used for host cell entry and immune response modulation. Information was obtained from OralInt predicted PPIs and the literature \[[@B59]--[@B63]\].](BMRI2017-1734151.002){#fig2}

![Summary diagram of the proposed ZIKV targets considering the intra- and extracellular localization of the viral proteins during the infection cycle. Scores of the OralInt predicted PPIs are presented next to each human protein target and refer to interaction with the specific ZIKV protein. The proposed membrane orientation of the ZIKV proteins was modified from Figure 25.4 in Shi and Gao (2017) \[[@B54]\].](BMRI2017-1734151.003){#fig3}

###### 

Number of interactions between human and ZIKV proteins predicted by OralInt according the score (0.9--1: very high confidence; 0.7--0.9: high confidence; 0.7--0.4: medium confidence). Quantification refers to the number of human proteins which have been identified as being expressed upon ZIKV infection of fibroblast (skin) and human cortical neuronal progenitor cells (hNPCs).

  *Zika* protein   OralInt score 0.9--1   OralInt score 0.7--0.9   OralInt score 0.4--0.7                         
  ---------------- ---------------------- ------------------------ ------------------------ ----------- --------- ---------------
  Capsid (C)       \-                     \-                       168                      64          3236      1055 + 14 (4)
  Envelope (E)     7                      3                        124                      42 + 1      2757      838 + 11 (3)
  Membrane (M)     1                      \-                       67                       15          1314      369 + 3
  NS1              3                      \-                       119                      39 + 1      2612      824 + 10 (3)
  NS2A             2                      1                        264                      81 + 1      4478      1486 + 17 (6)
  NS2B             11                     7                        439                      148 + 2     4649      1604 + 18 (4)
  NS3              1                      1                        33                       12 + 1      979       304 + 3 (1)
  NS4A             \-                     \-                       124                      41 + 1      2618      840 + 12 (3)
  NS4B             9                      \-                       292                      83 + 1      3858      1189 + 12 (4)
  NS5              5                      2                        229                      78 + 1      3970      1330 + 17 (5)
                                                                                                                  
  *Total*          *39*                   *14*                     *1859*                   *603 + 9*   *30471*   *9869 + 103*

^**∗**^\[[@B58]\]; ^**∗∗**^\[[@B17]\].

###### 

Number of human proteins establishing PPIs exclusively with each ZIKV protein; human proteins expression regulation upon ZIKV infection (when available) and respective presence in saliva. Only PPIs with scores ≥ 0.4 are shown.

  *Zika* protein   Total PPIs   Human proteins with expression data^*∗*^   Proteins present in saliva^*∗∗*^   
  ---------------- ------------ ------------------------------------------ ---------------------------------- ----
  E                105          16                                         21                                 8
  M                62           8                                          9                                  3
  NS1              131          16                                         14                                 4
  NS2A             638          85                                         94                                 22
  NS2B             1066         214                                        175                                45
  NS3              1            \-                                         1                                  \-
  NS4A             46           5                                          7                                  3
  NS4B             300          37                                         43                                 8
  NS5              557          90                                         106                                22

^**∗**^Quantification in human cortical neural progenitor cells (hNPCs) \[[@B58]\] and skin (fibroblasts) \[[@B17]\]. ^**∗∗**^Presence in saliva from OralCard \[[@B66], [@B67]\].

###### 

Membrane receptors as potential targets for ZIKV entry into host cells. Only proteins establishing PPIs with scores ≥ 0.2 are presented (OralInt prediction).

  Endocytosis receptors              Type of receptor   Gene name   UniprotKB AC   PPI score   Fold change hNPCs^*∗*^   
  ---------------------------------- ------------------ ----------- -------------- ----------- ------------------------ -----
  Clathrin-dependent endocytosis     GRPCR              ADRB2       P07550         0.4                                  3.6
  ADRB3                              P13945             0.3         0.4                                                 
  ADRB1                              P08588             0.2         0.2                                                 
  CCR5                               P51681             0.2                                                             
  CXCR4                              P61073             0.2                                                             
  LDLR                               LDLR               P01130      0.2                        1.2                      
  RTK                                EGFR               P00533      0.3                                                 
  ERBB4                              Q15303             0.2                                                             
  FGFR2                              P21802             0.2                        1.7                                  
  FGFR3                              P22607                         0.2            −1.5                                 
  FGFR4                              P22455             0.2                                                             
  MET                                P08581             0.4                                                             
  PDGFRA                             P16234             0.3                                                             
  TFR                                TFRC               P02786                     0.2                                  
  TGFBR                              TGFBR2             P37173      0.3            0.3                                  
  TGFBR3                             Q03167             0.3                                                             
  TGFBR1                             P36897             0.2                                                             
                                                                                                                        
  Clathrin-independent endocytosis   Caveolin           CAV2        P51636         0.2         0.2                       
  CAV3                               P56539             0.2         0.6                                                 
  Others                             CD81               P60033      0.3            0.4         −1.2                     
  CLDN1                              O95832             0.3         0.3            2.5                                  
  IL2RG                              P31785             0.3                                                             
  OCLN                               Q16625                                        −1.3                                 
  TIM                                HAVCR2             Q8TDQ0      0.4            0.2                                  
  TAM                                AXL                P30530      0.2                        1.3                      
  DC-SIGN                            CD209              Q9NNX6      0.2            0.2                                  
  L-SIGN                             CLEC4M             Q9H2X3      0.2            0.2                                  

^*∗*^Human cortical neural progenitor cells (hNPCs) \[[@B58]\].

###### 

PPIs established between the different ZIKV proteins and cell receptors and other proteins with an effector or signalling role in the immune response. Only proteins establishing PPIs with scores ≥ 0.2 are presented (OralInt prediction).

  Pathway              Gene Name      UniprotKB AC   OralInt score   Fold change hNPCs^*∗*^   Fold change skin 6 h^*∗∗*^   Fold change skin 24 h^*∗∗*^                                               
  -------------------- -------------- -------------- --------------- ------------------------ ---------------------------- ----------------------------- ----- ----- ----- ----- ----- ------ ------ ------
  IFN receptor         IFNAR1         P17181         0.3                                      0.2                          0.2                           0.3         0.2         0.3   −1.3   −1.4   −1.3
  IFNAR2               P48551         0.2                                                                                  0.2                                             0.2                       
                                                                                                                                                                                                     
  Toll-like receptor   TLR2           O60603         0.3                                      0.3                          0.3                           0.2         0.2   0.4   0.3                  
  TLR4                 O00206         0.3                            0.2                      0.4                          0.3                                 0.2   0.3   0.2                       
  TLR5                 O60602                                                                                                                                                                        
  TLR6                 Q9Y2C9         0.2            0.2                                      0.2                          0.5                                 0.4   0.3   0.2                       
                                                                                                                                                                                                     
  Complement           C2             P06681         0.2             0.3                                                                                 0.3   0.3   0.2                              
  C3                   P01024                                                                 0.3                                                              0.5   0.5   0.4                       
  C4A                  P0C0L4         0.2            0.2                                                                   0.2                           0.2   0.3   0.3   0.4                       
  C4B                  P0C0L5         0.2            0.2                                                                   0.2                           0.2         0.3   0.3                       
  C5                   P01031         0.2            0.3             0.3                      0.3                          0.3                           0.4   0.2   0.2                             
  C6                   P13671         0.3            0.7             0.2                      0.5                          0.5                           0.4         0.2   0.2                       
  C7                   P10643         0.3            0.2                                      0.2                          0.2                                       0.2   0.2                       
  C8A                  P07357                        0.3                                      0.4                          0.3                           0.3   0.4   0.3   0.3                       
  C8B                  P07358         0.5            0.6             0.5                      0.4                          0.5                           0.6   0.4   0.5   0.6                       
  C8G                  P07360         0.3            0.4             0.2                      0.3                          0.5                           0.3   0.3   0.5   0.3                       
  C9                   P02748                        0.2                                      0.2                                                              0.3   0.0                             
                                                                                                                                                                                                     
  Cytokines            IL1B           P01584         0.3                                      0.3                          0.4                           0.2   0.2   0.2   0.3   0.4          −3.2   −5.3
  IL6                  P05231         0.4            0.3             0.4                      0.2                                                        0.3   0.2   0.4   0.4         1.1    8.2    
  IL17                 Q16552         0.4            0.6             0.4                      0.2                          0.5                           0.3   0.4   0.6   0.4                       
  IL17F                Q96PD4                        0.2                                                                   0.2                                 0.2                                   
  IL23A                Q9NPF7                        0.2                                                                   0.4                                 0.2                                   
  IL31                 Q6EBC2         0.4            0.4             0.3                      0.2                          0.3                           0.3   0.2   0.4   0.4                       
  CD40L                P29965         0.2                                                     0.3                                                        0.2   0.2   0.2   0.2                       
  IFNG                 P01579         0.2                                                                                  0.4                                 0.5         0.2                       
  TNFA                 P01375                                                                 0.2                                                                                      −1.7   −2.1   
  IL22                 Q9GZX6                                                                                                                                        0.2                             
  IL21                 Q9HBE4                        0.3                                                                   0.3                                 0.3   0.3                             
  IL33                 O95760                                        0.2                                                                                                   0.2                       
  IL4                  P05112         0.3            0.5             0.4                      0.3                          0.3                           0.2   0.4   0.7   0.2                       
  IL10                 P22301         0.2            0.2             0.2                      0.2                          0.3                           0.2   0.2   0.3   0.2                       
  IL25                 Q9H293         0.3                            0.3                      0.2                          0.2                                 0.2   0.3   0.3                       
                                                                                                                                                                                                     
  Chemokines           CCL2 (MCP-1)   P13500                                                                                                                                                          
  CCL3 (MIP-1a)        P10147         0.2            0.2             0.2                      0.2                          0.4                           0.2         0.2   0.2         −1.7   −1.4   
  CCL4 (MIP-1*β*)      P13236         0.4            0.2             0.3                      0.3                          0.5                           0.4   0.4   0.4   0.5                       
  CXCL1 (Gro-a)        P09341         0.6            0.5             0.6                      0.6                          0.7                           0.4   0.5   0.7   0.4                       
  CXCL2 (Gro-*β*)      P19875         0.6            0.5             0.6                      0.6                          0.7                           0.4   0.5   0.7   0.4                       
  CXCL3                P19876         0.6            0.5             0.6                      0.6                          0.7                           0.4   0.5   0.7   0.4                       
  CXCL8 (IL-8)         P10145         0.2            0.5             0.3                      0.3                          0.5                                 0.5   0.5   0.2         −2.8   3.7    

^*∗*^Human cortical neural progenitor cells (hNPCs) \[[@B58]\]. ^*∗∗*^Skin (fibroblasts) \[[@B17]\].

###### 

PPIs established between the nonstructural proteins of ZIKV and proteins of the host pathways leading to an antiviral state. Only proteins establishing PPIs with scores ≥ 0.2 are presented (OralInt prediction).

  Pathway                                             Gene name        UniprotKB AC   PPI score with NS1   PPI score with NS2A   PPI score with NS2B   PPI score with NS3   PPI score with NS4A   PPI score with NS4B   PPI score with NS5   Fold change hNPCs   Fold change skin 6 h   Fold change skin 24 h
  --------------------------------------------------- ---------------- -------------- -------------------- --------------------- --------------------- -------------------- --------------------- --------------------- -------------------- ------------------- ---------------------- -----------------------
  IFN receptor                                        IRF9             Q00978                              0.2                                                                                                          0.2                                                              
  JAK1                                                P23458           0.2            0.3                  0.4                                         0.3                  0.4                   0.3                   1.3                                                             
  TYK2                                                P29597           0.3            0.3                  0.3                                         0.2                  0.3                   0.2                   1.5                                                             
                                                                                                                                                                                                                                                                                        
  Toll-like receptor                                  TNF              P01375                              0.2                                                                                                                                                   −1.7                   −2.1
  IRAK1                                               P51617                          0.2                  0.2                                         0.2                  0.2                   0.2                   −1.3                 1.4                 1.6                    
  IRAK2                                               O43187           0.3            0.3                  0.3                                                              0.3                   0.2                                                                                   
  IRAK4                                               Q9NWZ3                          0.2                  0.2                                                                                    0.2                                                                                   
  IKBKG (NEMO)                                        Q9Y6K9           0.3            0.2                  0.2                                         0.2                  0.3                   0.2                                                                                   
  MYD88                                               Q99836           0.4            0.4                  0.2                                         0.2                  0.3                   0.2                   −1.8                 −1.0                1.8                    
  NFKB                                                P19838           0.2            0.3                  0.4                   0.2                   0.2                  0.2                   0.4                   1.3                  1.2                 1.6                    
  TLR7                                                Q9NYK1                                                                                                                                                                                 −1.7                −1.4                   
  TLR8                                                Q9NR97                                                                                                                                                                                 −1.7                −1.4                   
  TLR9                                                Q9NR96                                                                                                                                                                                 −1.0                −2.3                   
  TBK1                                                Q9UHD2                          0.2                  0.2                                                                                                          1.6                  −1.2                1.1                    
                                                                                                                                                                                                                                                                                        
  RIG-like receptor                                   DDX3X (DDX3)     O00571                                                    0.2                                                                                                                             1.3                    −1.1
  IKBKE (IKK*ε*)                                      Q14164                          0.3                  0.4                                         0.2                  0.2                                                                                                         
  TRIM25                                              Q14258           0.4            0.6                  0.4                                         0.3                  0.4                   0.4                                        1.4                 1.8                    
  STAT1                                               P42224           0.8            0.5                  0.7                   0.7                   0.6                  0.6                   0.8                                        1.1                 1.8                    
  STAT2                                               P52630           0.3            0.3                                                              0.2                  0.3                   0.2                                                                                   
  DDX58 (RIG-I)                                       O95786           0.2            0.2                  0.2                                                                                                          2.0                  −3.2                4.9                    
                                                                                                                                                                                                                                                                                        
  PKR-RNA and stress sensors (apoptosis modulation)   CASP8            Q14790                                                                                                                                                                                    2.0                    1.3
  CASP10                                              Q92851                                                                                                                                      0.2                                        3.3                 3.3                    
  FADD                                                Q13158                                                                                                                0.2                   0.1                   1.5                  −1.3                −1.1                   
  RIPK1 (RIP1)                                        Q13546           0.2            0.2                  0.5                                         0.3                  0.3                   0.2                                        1.6                 1.4                    
  TRADD                                               Q15628                                                                                                                                                                                 1.5                 1.3                    
                                                                                                                                                                                                                                                                                        
  Mitochondria antiviral immunity                     IFNA1 (IFN*α*)   P01562                                                                                               0.2                   0.2                                                            2.3                    3.4
  IFNB1 (IFN*β*)                                      P01574           0.3                                 0.2                   0.3                   0.2                  0.3                   0.4                                        −1.7                3.7                    
                                                                                                                                                                                                                                                                                        
  Toll/mitochondria antiviral immunity                TRAF6            Q9Y4K3         0.4                  0.5                   0.2                   0.2                  0.2                   0.4                   0.5                  1.3                 1.3                    −1.1
  IFIH1 (MDA5)                                        Q9BYX4           0.4            0.5                  0.4                   0.4                   0.4                  0.3                   0.6                                        −1.4                7.3                    
                                                                                                                                                                                                                                                                                        
  RIG/mitochondria antiviral immunity                 IRF3             Q14653                              0.3                                                                                    0.2                   0.2                                      −1.1                   −1.1
  MAVS                                                Q7Z434                                                                                                                                                            −1.3                 −1.0                −1.5                   
                                                                                                                                                                                                                                                                                        
  Toll/RIG/mitochondria antiviral immunity            CHUK (IKK*α*)    O15111         0.3                  0.3                   0.4                   0.2                  0.4                   0.2                   0.3                  1.3                 1.0                    1.2
  IKBKB (IKK*β*)                                      O14920           0.2            0.4                  0.6                                         0.4                  0.2                   0.2                   −1.9                 1.7                 1.1                    
  IRF7                                                Q92985           0.2                                 0.2                                         0.2                  0.2                   0.3                   1.6                  1.3                 3.2                    

^*∗*^Human cortical neural progenitor cells (hNPCs) \[[@B58]\]. ^*∗∗*^Skin (fibroblasts) \[[@B17]\].
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